These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ocular complications of phenothiazines. Mathalone MB Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613 [No Abstract] [Full Text] [Related]
3. [Ophthalmologic study of patients receiving psychotropic drugs]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196 [No Abstract] [Full Text] [Related]
4. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472 [No Abstract] [Full Text] [Related]
5. Ocular effects of phenothiazine derivatives and reversibility. Mathalone MB Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561 [No Abstract] [Full Text] [Related]
6. Ocular complications related to phenothiazines. Siddall JR Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740 [No Abstract] [Full Text] [Related]
8. [Damage to eyes through conservative therapy]. Kleberger E Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408 [No Abstract] [Full Text] [Related]
9. Toxic effects of phenothiazines on the eye. Boet DJ Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274 [No Abstract] [Full Text] [Related]
10. [Ocular involvement during prolonged treatment with neuroleptics]. Nouri A; Cuendet JF Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196 [No Abstract] [Full Text] [Related]
11. [Ultrastructural study of ocular pigmentation due to phenothiazines]. Sizaret P; Rossazza C; Brassart B Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727 [No Abstract] [Full Text] [Related]
12. Electro-oculography as a diagnostic aid in phenothiazin retinopathy. Henkes HE Trans Ophthalmol Soc U K (1962); 1967; 87():285-7. PubMed ID: 5255224 [No Abstract] [Full Text] [Related]
14. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes. Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031 [TBL] [Abstract][Full Text] [Related]
15. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs]. Francesconi G; Di Tizio A; Cameo D Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709 [No Abstract] [Full Text] [Related]
16. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years). Goldman D Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486 [No Abstract] [Full Text] [Related]
17. Cutaneous and ocular changes associated with the use of chlorpromazine. Wolf ME; Richer S; Berk MA; Mosnaim AD Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679 [TBL] [Abstract][Full Text] [Related]
18. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy. Baron JB; Rivoalan Y; Morel P Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348 [No Abstract] [Full Text] [Related]
19. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study. Prien RF; DeLong SL; Cole JO; Levine J Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574 [No Abstract] [Full Text] [Related]
20. [Ocular complications in long-term chlorpromazine treatment]. Klíma M; Klímová A Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908 [No Abstract] [Full Text] [Related] [Next] [New Search]